Presymptom Health is a pioneering medtech company that creates diagnostic tests to detect illnesses earlier to help save lives.
Established to exploit a ground-breaking innovation to detect sepsis in patients up to three days before symptoms appear, Presymptom Health is currently seeking up to £2M over two years to continue the development of our clinical diagnostic test portfolio. This will include tests for use at both point-of-care and within central laboratory settings.
Presymptom Health is open to investment discussions to join us on our journey to create a truly revolutionary test for sepsis.
Find out morePresymptom Health has a development plan to extend its clinical diagnostic test portfolio to include tests for both point of care and within central laboratories.
Find out more